2022 American Transplant Congress » Kidney Immunosuppression: Desensitization

7:00pm-8:00pm

A2/A2B to B Kidney Transplantation Outcomes: A Single-Center 5 Year Experience

A. El Chediak, S. Shawar, M. Fallahzadeh, I. Feurer, S. Rega, J. L. Triozzi, D. Shaffer

7:00pm-8:00pm

Desensitization Protocol Consisting of High-Dose Intravenous Immunoglobulin, Plasmapheresis, and Rituximab in Highly Sensitized Kidney Transplant Recipients

M. Okada, T. Hiramitsu, T. Tomosugi, K. Futamura, S. Narumi, N. Goto, Y. Watarai

7:00pm-8:00pm

Desensitization Protocol to Prevent Severe Oliguric Antibody-Mediated Rejection

H. Ishida¹, K. Unagami¹, T. Kamzawa¹, K. Omoto¹, H. Shimizu¹, K. Tanabe²

7:00pm-8:00pm

Excellent Long-Term Outcome of ABO-Incompatible Living Kidney Transplantation by Reduced-Session of Plasmapheresis of Desensitization Protocol

Y. Ishiyama¹, K. Tanabe², T. Kanzawa², K. Unagami², H. Ishida², T. Takagi²

7:00pm-8:00pm

Obinutuzumab in Kidney Transplantation: Effect on B-cell Counts and Crossmatch Tests

M. M. Nasrallah¹, M. Elalfy¹, Y. Elmesseery², I. Amer¹, P. Malvezzi³, L. Rostaing⁴

7:00pm-8:00pm

Outcomes of Hlai Kidney Transplants in Patients with Cpra 100% After Desensitization

A. A. Vo¹, J. Tang¹, S. Williamson¹, C. Meyers¹, E. Huang¹, X. Zhang², M. Haas³, A. Peng¹, R. Najjar¹, S. Supreet¹, N. Ammerman¹, K. Lim¹, M. Gillespie¹, N. Badash¹, S. Jordan¹

7:00pm-8:00pm

Outcomes of Post-Operative Plasmapheresis in African American Kidney Transplant Recipients with High Panel Reactive Antibodies – A Single Center Experience

B. Valdepenas, M. Campara, J. Benken, C. Muran, D. Pierce, K. Heagler, P. DiCocco, J. Almario Alvarez, M. Spaggiari, I. Tang, I. Tzvetanov, E. Benedetti

7:00pm-8:00pm

Temporary Donor Splenic Transplant (Splenopheresis) in Simultaneous Kidney Transplant Provides a Safe Immunologic Window in Sensitized Patients

P. Di Cocco¹, S. Gaitonde², M. Spaggiari³, A. M. Fratti³, S. Akshelyan³, A. Jorge¹, E. Benedetti³, I. Tzvetanov³

7:00pm-8:00pm

Two Times or More Double-Filtration Plasmapheresis Increases the Risk of Bleeding During Kidney Transplantation

T. Kanzawa, T. Tagisawa, M. Furusawa, K. Unagami, K. Kitajima, K. Omoto, H. Ishida, K. Tanabe, T. Takagi

7:00pm-8:00pm

Validation of Donor Specific Antibody Characteristics Associated with Deleterious Outcomes: A Single Center Study of 940 Kidney Allograft Recipients

P. Lamba¹, I. Lamba¹, R. Friedlander², V. Sharma³, J. Lee², J. B. Lee⁴, C. Hartono⁵, M. Thangamani⁶, D. Sawinski², T. Salinas⁷, M. Suthanthiran⁸, D. Dadhania⁹